Top 5 Clean Energy Stocks To Invest In 2018


When the IRS Wants Your Life Insurance Policy

5 New Facts on DOLs Fiduciary Rule Delay

Let Clients Figure the Retirement Funding Catastrophe Out for Themselves

Alex Azar II, the nominee to be the next secretary of the U.S. Department of Health and Human Services (HHS), today told Democratic senators that he will agree with them about many issues but will probably disagree with them about the Affordable Care Act.

Azar talked about the ACA often today at a hearing on his nomination organized by the Senate Health, Education, Labor and Pensions Committee.


Sen. Elizabeth Warren, D-Mass, asked Azar what he thinks about “repealing and replacing” the health law.

“I guarantee that you and I will fundamentally differ on the contours of a system to do that,” Azar told her.

But Azar also praised the Medicare payment reform efforts organized by Sylvia Mathews Burwell, former President Barack Obama’s second HHS secretary, and he said he would do his best to run any Affordable Care act programs that survive as well as he could.

Top 5 Clean Energy Stocks To Invest In 2018: Merck & Company, Inc.(MRK)


Advisors’ Opinion:

  • [By David Zeiler]

    Pharma stocks shot up in the wake of Donald Trump’s victory. Eli Lilly and Co. (NYSE: LLY) and Merck & Co. (NYSE: MRK) both rose about 6%, while Pfizer Inc. (NYSE: PFE) jumped 7%.

  • [By Paul Ausick]

    Merck & Co. Inc. (NYSE: MRK) traded down 1.41% at $63.52. The stock’s 52-week range is $53.59 to $66.80. Volume was 15% below the daily average of around 9.2 million shares. The company had no specific news Friday.

  • [By Jayson Derrick]

    But the Dow component isn’t the only stock within the health care sector to see recent gains. The same trend can be seen in other large cap pharmaceutical names, including Merck & Co., Inc. (NYSE: MRK) and Pfizer Inc. (NYSE: PFE).

  • [By Chris Lange]

    Merck & Co. (NYSE: MRK) reported its fourth-quarter financial results before the markets opened on Thursday. The company posted $0.89 in earnings per share (EPS) and $10.12 billion in revenue, versus consensus estimates of$0.89 in EPS and revenue of $10.22 billion. In the same period of last year, the pharma giant posted EPS of $0.93 and $10.22 billion in revenue.

  • [By Paul Ausick]

    Merck & Co. Inc. (NYSE: MRK) traded up 0.93% at $66.07. The stock’s 52-week range is $65.40 to $66.80. Volume was around 10% below the daily average of about 8.8 million shares. The company had no specific news, but like J&J got a boost from the healthcare bill.

  • [By Ben Levisohn]

    Bristol-Myers Squibbannounced after the close that they have decided to not pursue an accelerated filing strategy for their Opdivo+Yervoy combination in 1st line metastatic/advanced non-small cell lung cancer (NSCLC). We spoke to the company and they could not say much beyond what was in the press release, but we assume the decision was based at least in part on data they may have seen from the single-arm CheckMate-568 (CM-568) study, which is expected to be completed this month. [Last night’s] update will pressure Bristol-Myers Squibb shares, where enthusiasm on the combo has been building, while leading to a rally in the shares of key competitor Merck (MRK).

Top 5 Clean Energy Stocks To Invest In 2018: Halliburton Company(HAL)


Advisors’ Opinion:

  • [By Ben Levisohn]

    When Weatherford International (WFT) announced that it had named Halliburton (HAL) CFO Mark McCollumits new CEO, its shares jumped as some observers contended itincreased the odds of an acquisition by the oil-services giant. It looks like they picked the wrong oil-services giant, however, as Weatherford and Schlumberger (SLB) announced a joint venture late Friday, one that has sent Weatherford’s shares soaring and earned it an upgrade from Wells Fargo analystsJudson Bailey andColeman Sullivan. They explain why:

  • [By Wayne Duggan]

    Trump is particularly enthusiastic about shale oil & gas and clean coal, which is good news for stocks such as Chesapeake Energy Corporation (NYSE: CHK), Halliburton Company (NYSE: HAL) and CONSOL Energy Inc. (NYSE: CNX).

  • [By ]

    KBR (NYSE: KBR)
    Though an under-the-radar name, KBR was the construction arm of oilfield services giant Halliburton (NYSE: HAL) before being spun off. With a consolidated market cap of $2.6 billion, KBR describes itself, per its website, as a “global provider of differentiated professional services and technologies within the Government Services and Hydrocarbon sectors.”

  • [By Lisa Levin]

    Halliburton Company (NYSE: HAL) reported stronger-than-expected profit for its third quarter on Monday.

    Halliburton posted quarterly adjusted earnings of $0.42 per share on revenue of $5.44 billion. However, analysts expected earnings of $0.37 per share on revenue of $5.35 billion.

Top 5 Clean Energy Stocks To Invest In 2018: Plantronics Inc.(PLT)

Advisors’ Opinion:

  • [By Lisa Levin]

    Shares of Plantronics Inc (NYSE: PLT) were down 25 percent to $33.36. Plantronics reported better-than-expected third-quarter earnings, but the company’s revenue missed analysts’ expectations. The company announced a new 1 million share buyback plan and issued a weak earnings forecast for the fourth quarter.

Top 5 Clean Energy Stocks To Invest In 2018: Cytokinetics, Incorporated(CYTK)


Advisors’ Opinion:

  • [By Lisa Levin] Gainers
    Marathon Patent Group Inc (NASDAQ: MARA) shares surged 30.2 percent to $5.01 after dropping 40.86 percent on Tuesday. Marathon Patent Group filed for sale of 1.85 million shares of common stock by selling stockholders.
    Capricor Therapeutics Inc (NASDAQ: CAPR) shares jumped 17.2 percent to $2.25 after the company reported the FDA clearance of Investigational New Drug application for CAP-1002.
    Rite Aid Corporation (NYSE: RAD) gained 13.2 percent to $2.15 following 16.5 percent rally on Tuesday.
    Photronics, Inc. (NASDAQ: PLAB) shares climbed 11.8 percent to $10.45 after the company reported stronger-than-expected earnings for its fourth quarter.
    China Distance Education Hldgs Ltd (ADR) (NYSE: DL) shares surged 11.3 percent to $8.67. China Distance Education reported Q4 profit of $5.9 million on revenue of $41.7 million.
    Cytokinetics, Inc. (NASDAQ: CYTK) shares gained 11 percent to $8.05 after falling 7.05 percent on Tuesday.
    Ooma Inc (NYSE: OOMA) shares surged 8.5 percent to $10.85 as the company posted strong Q3 results.
    Nuance Communications Inc. (NASDAQ: NUAN) climbed 8 percent to $17.12 after the company reported stronger-than-expected results for its fourth quarter on Tuesday.
    American Superconductor Corporation (NASDAQ: AMSC) surged 7.8 percent to $3.59 after the company reported $8 million in D-VAR system orders.
    Thermon Group Holdings Inc (NYSE: THR) rose 6.3 percent to $24.17. William Blair upgraded Thermon Group from Market Perform to Outperform.
    Domino's Pizza, Inc. (NYSE: DPZ) surged 6.1 percent to $182.88. Nomura upgraded Domino's from Neutral to Buy.
    Xencor Inc (NASDAQ: XNCR) rose 5.9 percent to $21.17. Cantor Fitzgerald initiated coverage on Xencor with an Overweight rating.
    Idera Pharmaceuticals Inc (NASDAQ: IDRA) gained 5.1 percent to $2.28 after the company disclosed that it has been granted FDA Fast Track designation for IMO-2125.
    Regal Entertainment Group (NYSE: RGC) gained 5.1 percent to
  • [By Lisa Levin]

    Cytokinetics, Inc. (NASDAQ: CYTK) shares dropped 27 percent to $8.12 on the back of negative trial results for its amyotrophic lateral sclerosis, or ALS, treatment candidate tirasemtiv in a late-stage study. The results of the international Phase 3 study showed tiraemtive did not meet the primary endpoint of change from baseline in slow vital capacity, or SVS, evaluated at 24 weeks, as well the secondary endpoints evaluated at 48 weeks.

  • [By Chris Lange]

    Cytokinetics, Inc. (NASDAQ: CYTK) saw its shares take a massive step back in Tuesdays session after the firm reported negative results for its trial in amyotrophic lateral sclerosis (ALS). Specifically, the firms Phase 3 clinical trial of tirasemtiv did not meet the primary endpoint or any of the secondary endpoints.

Top 5 Clean Energy Stocks To Invest In 2018: XTL Biopharmaceuticals Ltd.(XTLB)

Advisors’ Opinion:

  • [By Lisa Levin]

    X T L Biopharmaceuticals Ltd (ADR) (NASDAQ: XTLB) shares dropped 38 percent to $2.21 after the company reported a $2.5 million registered direct offering.

Leave a Reply

Your email address will not be published. Required fields are marked *